As supernatants of TRAIL-treated cells were also able to polarize human CD14+ cells toward HLA-DRlo/neg CD206+ cells in vitro, it is conceivable that TRAIL-induced cytokines may not only recruit myeloid cells to, but also promote their polarization within, the tumor microenvironment. The gene discussed is CD14; the disease is neoplasm.